|
|
Volumn 132, Issue 3, 1992, Pages 351-358
|
|
The combined use of 131I-labeled antibody and the hypoxic cytotoxin SR 4233 in vitro and in vivo
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBODY;
CYTOTOXIN;
IODINE 131;
TIRAPAZAMINE;
ANTINEOPLASTIC AGENT;
RADIATION SENSITIZING AGENTS;
RADIOACTIVE IODINE;
RADIOSENSITIZING AGENT;
TRIAZINE DERIVATIVE;
AEROBIC METABOLISM;
ANIMAL EXPERIMENT;
ANTIBODY LABELING;
ARTICLE;
BODY WEIGHT;
CELL CYCLE;
CLONOGENIC ASSAY;
COLON ADENOCARCINOMA;
CONTROLLED STUDY;
CYTOTOXICITY;
DOSE RESPONSE;
DOSIMETRY;
FEMALE;
HUMAN;
HUMAN CELL;
HYPOXIA;
INTRAPERITONEAL DRUG ADMINISTRATION;
MOUSE;
MULTICELLULAR SPHEROID;
NONHUMAN;
PRIORITY JOURNAL;
RADIOIMMUNOTHERAPY;
REOXYGENATION;
TUMOR VOLUME;
XENOGRAFT;
ADENOCARCINOMA;
ANIMAL;
CELL CULTURE;
COLON TUMOR;
EXPERIMENTAL NEOPLASM;
IN VITRO STUDY;
MULTIMODALITY CANCER THERAPY;
NUDE MOUSE;
RADIATION EXPOSURE;
ADENOCARCINOMA;
ANIMAL;
ANTINEOPLASTIC AGENTS;
COLONIC NEOPLASMS;
COMBINED MODALITY THERAPY;
HUMAN;
IN VITRO;
IODINE RADIOISOTOPES;
MICE;
MICE, NUDE;
NEOPLASMS, EXPERIMENTAL;
RADIATION-SENSITIZING AGENTS;
RADIOIMMUNOTHERAPY;
SUPPORT, U.S. GOV'T, P.H.S.;
TRANSPLANTATION, HETEROLOGOUS;
TRIAZINES;
TUMOR CELLS, CULTURED;
|
|
EID: 0027008371
PISSN: 00337587
EISSN: None
Source Type: Journal
DOI: 10.2307/3578244 Document Type: Article |
|
Times cited : (23)
|
|
References (0)
|
